Qtron Investments LLC Eli Lilly & CO Transaction History

Qtron Investments LLC

$716 Million
Q3 2024

A detailed history of Qtron Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Qtron Investments LLC holds 9,471 shares of LLY stock, worth $7.54 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

9,471

Previous 9,750 2.86%

Holding current value

$7.54 Million

Previous $8.83 Million 4.95%

% of portfolio

1.17%

Previous 1.3%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $215,427 - $267,845	-279 Reduced 2.86%	9,471 $8.39 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $475,514 - $596,330	656 Added 7.21%	9,750 $8.83 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $502,777 - $672,645	849 Added 10.3%	9,094 $7.07 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $131,822 - $155,401	-251 Reduced 2.95%	8,245 $4.81 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $237,780 - $327,817	547 Added 6.88%	8,496 $4.56 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $352,493 - $471,324	1,005 Added 14.47%	7,949 $3.73 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $329,267 - $386,709	-1,060 Reduced 13.24%	6,944 $2.38 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $108,362 - $126,263	337 Added 4.4%	8,004 $2.93 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $139,049 - $158,461	-469 Reduced 5.76%	7,667 $2.48 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $891,099 - $1.05 Million	3,197 Added 64.73%	8,136 $2.64 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $58,498 - $75,666	-324 Reduced 6.16%	4,939 $1.13 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $326,668 - $422,887	-1,988 Reduced 27.42%	5,263 $983,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $7,775 - $9,358	-57 Reduced 0.78%	7,251 $1.19 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $870,017 - $1.08 Million	7,308 New	7,308 $1.01 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $661,941 - $819,874	-6,191 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $171,077 - $186,088	-1,602 Reduced 20.56%	6,191 $692,000
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $347,769 - $405,935	3,139 Added 67.45%	7,793 $863,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $492,858 - $552,150	4,654 New	4,654 $539,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.

Account

Qtron Investments LLC Eli Lilly & CO Transaction History